Share Email Print
cover

Proceedings Paper

Photodynamic decontamination of blood for transfusion
Author(s): Ehud Ben-Hur; H. Margolis-Nunno; P. Gottlieb; S. Lustigman; Bernard Horowitz
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

Currently transfused cellular components of blood are not available in a sterile form and carry a small risk of transmitting viral and parasite diseases. Using phthalocyanines and red light, lipid enveloped viruses, e.g., HIV-1, can be inactivated in red blood cell concentrates (RBCC). Under conditions leading to virus sterilization the blood borne parasites Trypanosoma cruzi (Chagas disease) and Plasmodium falciparum (malaria) could be eliminated to undetectable levels (> 4 log10 kill). RBC damage during treatment could be avoided by increasing the light fluence rate to 80 mW/cm2, and by including the free radical scavenger glutathione and the vitamin E derivative Trolox during light exposure. Similar sterilization of platelet concentrates was achieved with the psoralen derivative AMT and UVA light. Platelet damage due to PUVA treatment was avoided by including the plant flavonoid rutin during irradiation. It is concluded that elimination of the risk of transmitting pathogens during blood transfusion is feasible with photochemical treatments.

Paper Details

Date Published: 12 January 1995
PDF: 8 pages
Proc. SPIE 2325, Photodynamic Therapy of Cancer II, (12 January 1995); doi: 10.1117/12.199140
Show Author Affiliations
Ehud Ben-Hur, New York Blood Ctr. (United States)
H. Margolis-Nunno, New York Blood Ctr. (United States)
P. Gottlieb, New York Blood Ctr. (United States)
S. Lustigman, New York Blood Ctr. (United States)
Bernard Horowitz, New York Blood Ctr. (United States)


Published in SPIE Proceedings Vol. 2325:
Photodynamic Therapy of Cancer II
Daniel Brault; Giulio Jori; Johan Moan; Benjamin Ehrenberg, Editor(s)

© SPIE. Terms of Use
Back to Top